Arecor Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 30
Employees
  • Stock Symbol
  • AREC
Stock Symbol
  • Share Price
  • $4.42
  • (As of Monday Closing)

Arecor General Information

Description

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Arestat, it is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.

Contact Information

Website
www.arecor.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
LON
Primary Office
  • Chesterford Research Park
  • Little Chesterford CB10 1XL
  • England, United Kingdom
+44 01223 000000

Arecor Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arecor Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.42 $3.41 $3.07 - $5.07 $122M 27.7M 15.1K -$0.13

Arecor Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-May-2019 FY 2018 31-May-2018
Revenue 2,176 2,176 971 1,811
EBITDA (4,185) (4,185) (3,492) (1,643)
Net Income (3,528) (3,528) (3,164) (1,501)
Total Assets 5,838 5,838 6,873 2,745
Total Debt 2,719 2,719 279 877
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arecor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arecor‘s full profile, request access.

Request a free trial

Arecor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Arecor‘s full profile, request access.

Request a free trial

Arecor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing inn
Drug Discovery
Little Chesterford, United Kingdom
30 As of 2021
000.00
00.00 0000-00-00
00000000 000.00

0000 000

eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
Macclesfield, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
000000000000

00000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Cambridge, United Kingdom
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arecor Competitors (65)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Redx Pharma Pending Transaction (PE) Macclesfield, United Kingdom 00 000.00 000000000000
00000 Formerly VC-backed Cambridge, United Kingdom 000 00000 000000&0 00000
0000000 0000000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 00000000000 00000
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 0 00000
0000000 0000000000 Formerly VC-backed Basel, Switzerland 000 00000 0000000000 00000
You’re viewing 5 of 65 competitors. Get the full list »

Arecor Executive Team (6)

Name Title Board Seat Contact Info
Sarah Howell Ph.D Chief Executive Officer & Board Member
Lindsey Foulkes Ph.D Chief Operating Officer
Jan Jezek Ph.D Chief Scientific Officer
David Gerring Director, Development
Susan Lowther Chief Financial Officer, Company Secratary & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Arecor Board Members (12)

Name Representing Role Since
Alan Smith Ph.D Self Board Member 000 0000
Alexander Crawford Calculus Capital Board Member 000 0000
Andrew Lane Unilever Ventures Board Member 000 0000
Andrew Richards Ph.D Self Chairman 000 0000
Sam Fazeli Ph.D Arecor Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Arecor Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial